Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers

T. Hasegawa, K. Yamaki, M. Nadai, I. Muraoka, L. Wang, K. Takagi, Toshitaka Nabeshima

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Recently, Chinese medicines have become available as OTC drugs and are frequently prescribed with Western medicine for the treatment of various chronic diseases. In this study, the effect of the Chinese medicines Sho-saiko-to (TJ-9), Rikkunshi-to (TJ-43) and Sairei-to (TJ-114) on the bioavailability of ofloxacin (OFLX) was investigated in seven volunteers in an open, random crossover fashion. Subjects received a single oral dose of OFLX (200 mg) alone and with coadministrations of each Chinese medicine, at one-week intervals. Plasma and urine samples were analyzed by high-performance liquid chromatography. No significant differences in any estimated bioavailability parameters of OFLX were observed between the two phases. The urinary recovery of OFLX excreted within 24 h after the administration of OFLX alone, 80.6 ± 3.9% (mean ± SEM), was not significantly different from those after the coadministrations of the Chinese medicines (79.7 ± 5.1% for TJ-9, 76.8 ± 2.3% for TJ-43 and 80.3 ± 5.3% for TJ-114), suggesting that there was no difference in the systemic availability of the four doses. These findings indicate that the Chinese medicines studied have no significant effect on the rate and extent of bioavailability of OFLX.

Original languageEnglish
Pages (from-to)57-61
Number of pages5
JournalInternational Journal of Clinical Pharmacology and Therapeutics
Volume32
Issue number2
Publication statusPublished - 29-03-1994
Externally publishedYes

Fingerprint

Ofloxacin
Biological Availability
Healthy Volunteers
Nonprescription Drugs
Volunteers
Chronic Disease
High Pressure Liquid Chromatography
Medicine
Urine
liu-jun-zi-tang
sairei-to
shosaiko-to

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Hasegawa, T. ; Yamaki, K. ; Nadai, M. ; Muraoka, I. ; Wang, L. ; Takagi, K. ; Nabeshima, Toshitaka. / Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers. In: International Journal of Clinical Pharmacology and Therapeutics. 1994 ; Vol. 32, No. 2. pp. 57-61.
@article{2753a546c42a4f83babb1911864e5725,
title = "Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers",
abstract = "Recently, Chinese medicines have become available as OTC drugs and are frequently prescribed with Western medicine for the treatment of various chronic diseases. In this study, the effect of the Chinese medicines Sho-saiko-to (TJ-9), Rikkunshi-to (TJ-43) and Sairei-to (TJ-114) on the bioavailability of ofloxacin (OFLX) was investigated in seven volunteers in an open, random crossover fashion. Subjects received a single oral dose of OFLX (200 mg) alone and with coadministrations of each Chinese medicine, at one-week intervals. Plasma and urine samples were analyzed by high-performance liquid chromatography. No significant differences in any estimated bioavailability parameters of OFLX were observed between the two phases. The urinary recovery of OFLX excreted within 24 h after the administration of OFLX alone, 80.6 ± 3.9{\%} (mean ± SEM), was not significantly different from those after the coadministrations of the Chinese medicines (79.7 ± 5.1{\%} for TJ-9, 76.8 ± 2.3{\%} for TJ-43 and 80.3 ± 5.3{\%} for TJ-114), suggesting that there was no difference in the systemic availability of the four doses. These findings indicate that the Chinese medicines studied have no significant effect on the rate and extent of bioavailability of OFLX.",
author = "T. Hasegawa and K. Yamaki and M. Nadai and I. Muraoka and L. Wang and K. Takagi and Toshitaka Nabeshima",
year = "1994",
month = "3",
day = "29",
language = "English",
volume = "32",
pages = "57--61",
journal = "International Journal of Clinical Pharmacology and Therapeutics",
issn = "0946-1965",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "2",

}

Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers. / Hasegawa, T.; Yamaki, K.; Nadai, M.; Muraoka, I.; Wang, L.; Takagi, K.; Nabeshima, Toshitaka.

In: International Journal of Clinical Pharmacology and Therapeutics, Vol. 32, No. 2, 29.03.1994, p. 57-61.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers

AU - Hasegawa, T.

AU - Yamaki, K.

AU - Nadai, M.

AU - Muraoka, I.

AU - Wang, L.

AU - Takagi, K.

AU - Nabeshima, Toshitaka

PY - 1994/3/29

Y1 - 1994/3/29

N2 - Recently, Chinese medicines have become available as OTC drugs and are frequently prescribed with Western medicine for the treatment of various chronic diseases. In this study, the effect of the Chinese medicines Sho-saiko-to (TJ-9), Rikkunshi-to (TJ-43) and Sairei-to (TJ-114) on the bioavailability of ofloxacin (OFLX) was investigated in seven volunteers in an open, random crossover fashion. Subjects received a single oral dose of OFLX (200 mg) alone and with coadministrations of each Chinese medicine, at one-week intervals. Plasma and urine samples were analyzed by high-performance liquid chromatography. No significant differences in any estimated bioavailability parameters of OFLX were observed between the two phases. The urinary recovery of OFLX excreted within 24 h after the administration of OFLX alone, 80.6 ± 3.9% (mean ± SEM), was not significantly different from those after the coadministrations of the Chinese medicines (79.7 ± 5.1% for TJ-9, 76.8 ± 2.3% for TJ-43 and 80.3 ± 5.3% for TJ-114), suggesting that there was no difference in the systemic availability of the four doses. These findings indicate that the Chinese medicines studied have no significant effect on the rate and extent of bioavailability of OFLX.

AB - Recently, Chinese medicines have become available as OTC drugs and are frequently prescribed with Western medicine for the treatment of various chronic diseases. In this study, the effect of the Chinese medicines Sho-saiko-to (TJ-9), Rikkunshi-to (TJ-43) and Sairei-to (TJ-114) on the bioavailability of ofloxacin (OFLX) was investigated in seven volunteers in an open, random crossover fashion. Subjects received a single oral dose of OFLX (200 mg) alone and with coadministrations of each Chinese medicine, at one-week intervals. Plasma and urine samples were analyzed by high-performance liquid chromatography. No significant differences in any estimated bioavailability parameters of OFLX were observed between the two phases. The urinary recovery of OFLX excreted within 24 h after the administration of OFLX alone, 80.6 ± 3.9% (mean ± SEM), was not significantly different from those after the coadministrations of the Chinese medicines (79.7 ± 5.1% for TJ-9, 76.8 ± 2.3% for TJ-43 and 80.3 ± 5.3% for TJ-114), suggesting that there was no difference in the systemic availability of the four doses. These findings indicate that the Chinese medicines studied have no significant effect on the rate and extent of bioavailability of OFLX.

UR - http://www.scopus.com/inward/record.url?scp=0028328860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028328860&partnerID=8YFLogxK

M3 - Article

C2 - 8004359

AN - SCOPUS:0028328860

VL - 32

SP - 57

EP - 61

JO - International Journal of Clinical Pharmacology and Therapeutics

JF - International Journal of Clinical Pharmacology and Therapeutics

SN - 0946-1965

IS - 2

ER -